The absence of FDA-approved GLP-1 patches also increases the risk for unexpected side effects and adverse reactions
IgG4-RD can cause swelling or lumps in the salivary or tear glands, persistent nasal congestion, unexplained swelling in other areas, abdominal pain, jaundice, or changes in kidney function
PubMed Simoneau G
This is why localized injections near the injury site are often more effective than general subcutaneous use
Lethal dose perspective For context, research indicates the lethal dose of GHK-CU in rodent models extrapolates to approximately 21,000mg for a 70kg human, roughly 330mg per kilogram of body weight
This frequently occurs with newer therapies that have recently entered the market, even when they have received approval from the U.S